Genetic Feature of Congenital Hearing Loss in Chinese Population
NCT ID: NCT06365749
Last Updated: 2024-04-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
50 participants
OBSERVATIONAL
2024-04-23
2026-11-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* to present the genetic characteristics of the infant with hearing loss in the Chinese population
* to build up a prognostic model base on diverse data.
Participants will be asked to receive audiological tests and collection of the peripheral blood sample.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genetic Analysis of Human Hereditary Hearing Impairment
NCT00001606
Genetic Studies of Tone Deafness
NCT00006076
Exome Analysis in Hearing Impaired Patients
NCT03557879
Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome
NCT06507007
Genetic Study of Age Related Hearing Loss
NCT01732289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neonate with hearing loss
Neonates who failed in the neonatal hearing screening programs, including oto-acoustic emissions and automated auditory brain stem response.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fail in the neonatal hearing screening programs, including oto-acoustic emissions and automated auditory brain stem response
* Promise to complete the tests required at baseline and follow-ups by the legal representative
* Informed consent by the legal representative
Exclusion Criteria
* Other explicit otologic conditions which could induce hearing loss, including cerumen, otitis media, congenital middle ear abnormalities, microtia and external ear abnormalities
* A drug with ototoxicity usage during pregnancy
* Other severe congenital anomalies
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dan Bing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dan Bing
associate professor
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TJ-IRB20221228
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.